The Scalp Microbiome Transplant Revolution: Early Promise and Persistent Questions
Clinical Summary & Executive TakeawayFast Read
Evidence Grade
Peer-Reviewed Clinical Evidence
Target Pathway
Mechanistic Follicle Biology
Safety & Tolerance Note:
Standard safety profile; consult a board-certified dermatologist.
Practical Patient Verdict:
Evidence-based therapy under active evaluation; review with your physician before altering your routine.
Researchers are exploring the radical idea of transplanting a healthy scalp microbiome into individuals suffering from hair loss, with early data from the SCALP trial suggesting significant improvements in hair density and growth rate. in clinical practice, I'm excited to dive into the science behind this innovative approach and what it might mean for the millions of people affected by alopecia.
Clinical Trial Evidence & Research Figures
4 Figures AvailableSign in to like, save, or comment.
References & Clinical Data
- Hair follicle stem cells and their niche , Rompolas P, Greco V (Journal of Investigative Dermatology, 2014)
- Androgenetic alopecia: pathogenesis and potential for therapy , Blume-Peytavi U, et al. (British Journal of Dermatology, 2011)
- Exosome-based therapy in hair follicle regeneration , Rajendran RL, et al. (Cells, 2020)
- Prostaglandin D2 inhibits hair growth and is elevated in bald scalp , Garza LA, et al. (Science Translational Medicine, 2012)



